In Vitro Transduction
In Vitro Transduction - Related Videos
10:14
Retroviral Transduction of T-cell Receptors in Mouse T-cells
0 Views •
Cited by 21 •
2010
We present a protocol to produce antigen-specific mouse T-cells using retroviral...
03:19
Transduction to Label PDX Tumor Cells: Introducing Lentivirus Expressing Fluorescent Marker into the Tumor Cell In Vitro
0 Views •
2023
The following video describes a technique of transduction to label (patient-derived xenografts) PDX tumor cells, which is used for introducing lentivirus expressing green-fluorescent protein and luciferase reporters into the tumor cell in vitro.
01:16
Transduction
0 Views •
2025
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
10:58
A Protocol for Lentiviral Transduction and Downstream Analysis of Intestinal Organoids
0 Views •
Cited by 81 •
2015
In this video protocol we give a step by step explanation of lentiviral transduction in organoids of primary intestinal epithelium and of processing and downstream analysis of these cultures by quantitative RT-PCR, RNA-microarray and immunohistochemistry.
04:27
An In Vitro Transduction-Induced Myelination Assay for Oligodendrocyte Precursor Cells
0 Views •
2025
The video demonstrates a protocol for differentiating oligodendrocyte precursor cells (OPCs) into oligodendrocytes and inducing myelination in a co-culture with dorsal root ganglion (DRG) neurons. The OPCs are transduced with lentiviral vectors encoding a signaling protein that regulates myelination. The transduced OPCs are co-cultured with DRG neurons to assess the differentiation into oligodendrocytes and the signaling protein-induced myelination.
FAQs
The process begins when a vector binds receptors on the surface of a target cell. This interaction supports cellular entry and release of the vector’s genetic cargo inside the cell. Cellular machinery then uses the delivered sequence to alter gene expression or produce a desired protein. Studying these stages helps researchers connect vector-cell interactions with the final experimental outcome.
Vector design influences how effectively genetic cargo reaches target cells and how safely the system functions. Exposure conditions also shape the result by determining how cells encounter the vector. Because efficiency and safety depend on both factors, researchers can adjust the vector and treatment conditions to improve delivery while maintaining a controlled experimental system.
Cell type, vector dose, and culture conditions are central variables because they affect how cells encounter, internalize, and respond to delivered genetic material. In vitro experiments allow each factor to be adjusted and measured under controlled conditions. This makes it possible to compare outcomes systematically and identify conditions that support the intended change in gene expression or protein production.
A typical workflow selects a cultured target cell population, exposes it to a suitable vector, and maintains the cells under defined culture conditions. Researchers then evaluate whether the delivered sequence changes gene expression or enables production of the desired protein. Adjusting dose, cell type, and culture conditions across experiments helps identify conditions associated with better efficiency or safety.
The outcome can be assessed by determining whether the delivered genetic sequence produces the intended change in gene expression or supports production of a desired protein. Results may also show whether the treated cells are suitable for establishing an engineered cell line. These measurements connect vector exposure conditions with functional changes in the cultured population.
In vitro transduction supports several controlled biological applications, including studying gene function, creating engineered cell lines, and producing recombinant proteins. It can also prepare cells for therapeutic or regenerative applications. Because researchers can control and measure dose, cell type, and culture conditions, the method helps link genetic manipulation with observable cellular outcomes before broader use.